Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality (ACM) and frequency of cardiovascular-related hospitalization (CVH)), with a Win Ratio of 1.8 (p<0.0001)
News | Pharmaceuticals
BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine

January 12, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home January 12, 2024
Home
The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication ― potentially allowing for an increase in donor hearts available for heart transplant patients
News | Cardiovascular Surgery
Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study

January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...

Home January 11, 2024
Home
New research from Mayo Clinic suggests that AI could improve the diagnosis of peripartum cardiomyopathy
News | Artificial Intelligence
Clinical Research Shows AI-enabled Digital Stethoscope can Detect Pregnancy-related Heart Disease

January 9, 2024 — New research from Mayo Clinic suggests that artificial intelligence (AI) could improve the diagnosis ...

Home January 09, 2024
Home
Study investigators Drs. Pedro Engel-Gonzalez and Gennaro Giustino from Henry Ford Health.
News | Heart Valve Technology
Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of enrollment in both their STIM-ADHF and STOP-ADHF pilot studies.
News | Cardiovascular Clinical Studies
Cardionomic Announces Enrollment Completion in the STIM-ADHF and STOP-ADHF Pilot Studies

January 3, 2024 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of ...

Home January 03, 2024
Home
The first patient was enrolled at the Cleveland Clinic on December 28, 2023
News | Atrial Fibrillation
Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

December 29, 2023 — Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety ...

Home December 29, 2023
Home
Results from an ongoing clinical study conducted by Scripps Clinic indicate that MindMics' non-invasive IH technology can detect aortic stenosis by capturing in-ear acoustic vibrations throughout the cardiac cycles
News | Patient Monitors
MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new ...

Home December 26, 2023
Home
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation
News | Atrial Fibrillation
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation (nsPFA) Cardiac Catheter

December 26, 2023 — Pulse Biosciences, Inc., a company primarily focused on leveraging its novel and proprietary CellFX ...

Home December 26, 2023
Home
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced that the first patient was enrolled and treated in its CardiALLO Allogeneic Mesenchymal Cell Therapy Phase I/II trial
News | Cardiovascular Clinical Studies
BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fraction

December 19, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home December 19, 2023
Home
News | Cardiovascular Clinical Studies
Clinical Trial Results from Peerbridge Health Unveil Direct-from-ECG Sleep Apnea Detection Using COR Wearable Platform

December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective ...

Home December 19, 2023
Home
Henry Ford Health's National Cardiogenic Shock Initiative research team.
News | Cardiovascular Clinical Studies
National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival

December 14, 2023 — Published results of a large, national heart attack study show that patients with a life-threatening ...

Home December 14, 2023
Home
Pulmonary arterial hypertension, a form of high blood pressure that occurs in the lungs, is a target of research by Cedars-Sinai investigators.
News | Hypertension
Unique Cell-based Approach for Pulmonary Arterial Hypertension Shown to Be Safe

December 13, 2023 —Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary ...

Home December 13, 2023
Home
Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.
News | Heart Valve Technology
Use of Anticoagulant Drug after Aortic Valve Replacement Lowers Mortality Risk, Mayo Clinic Study Finds

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement h ...

Home December 12, 2023
Home
New study reveals latest data on global burden of cardiovascular disease
News | Cardiovascular Clinical Studies
New Study Reveals Latest Data on Global Burden of Cardiovascular Disease

December 11, 2023 — A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely ...

Home December 11, 2023
Home
UC Gardner Neuroscience Institute
News | Stroke
UC Gardner Neuroscience Institute to Lead New National Stroke Study

December 8, 2023 — Ischemic stroke is the most common form of stroke in the U.S., affecting more than 690,000 people ...

Home December 08, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now